Demirpence E, Pons M, Balaguer P, Gagne D
INSERM U 58, Montpellier, France.
Biochem Biophys Res Commun. 1992 Feb 28;183(1):100-6. doi: 10.1016/0006-291x(92)91614-v.
We recently developed the cellular model MVLN-15 in which estrogenic action can be detected by bioluminescence. Using this cellular model, we characterized the inhibitory effect of retinoic acid on the estrogen-dependent induction of luciferase transcription. We present evidence that i) the inhibitory effect of retinoic acid is not due to a simple competition between retinoic acid and estradiol for binding to the estrogen receptor, ii) a DNA sequence restricted to an estrogen-responsive element (ERE) was sufficient for the antiestrogenic effect of retinoic acid, and iii) retinoic acid does not act via a cryptic AP-1 binding site associated with this ERE. Therefore, we conclude that the antiestrogenic effect of retinoic acid is due to an inhibition of estrogen receptor activity, for example by altering the amount of estrogen receptor protein bound to the ERE or affecting the transcriptional efficiency of this complex.
我们最近开发了细胞模型MVLN-15,在该模型中可通过生物发光检测雌激素作用。利用这个细胞模型,我们对维甲酸对荧光素酶转录的雌激素依赖性诱导的抑制作用进行了表征。我们提供的证据表明:i)维甲酸的抑制作用并非由于维甲酸与雌二醇在与雌激素受体结合上的简单竞争;ii)局限于雌激素反应元件(ERE)的DNA序列足以产生维甲酸的抗雌激素作用;iii)维甲酸并非通过与该ERE相关的隐蔽AP-1结合位点起作用。因此,我们得出结论,维甲酸的抗雌激素作用是由于对雌激素受体活性的抑制,例如通过改变与ERE结合的雌激素受体蛋白的量或影响该复合物的转录效率。